Clinical Trial: Can Baseline Peripheral Blood Inflammatory Markers Predict Early Neurological Deterioration After Thrombolysis in Acute Ischemic Stroke Patients? (China)

Posted On: 2026-09-21

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Can Baseline Peripheral Blood Inflammatory Markers Predict Early Neurological Deterioration After Thrombolysis in Acute Ischemic Stroke Patients?'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132857

Registration Time: 2026/09/18

Type: Observational study

Primary Sponsor: Beijing Tsinghua Changgung Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341889

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Can Baseline Peripheral Blood Inflammatory Markers Predict Early Neurological Deterioration After Thrombolysis in Acute Ischemic Stroke Patients? (China)